What is Brisdelle (paroxetine) and what does a “GoodRx price” usually mean?
Brisdelle is the brand name for paroxetine 7.5 mg, an oral prescription used to treat hot flashes associated with menopause. A “GoodRx price” is the discounted cash price you may pay at a participating pharmacy using a GoodRx coupon, not the price your insurance covers (and it may not be available everywhere) [1].
Is the GoodRx price for Brisdelle 7.5 mg “good”?
From the information provided, there’s not enough detail to confirm the exact GoodRx rate for Brisdelle 7.5 mg (prices change by:
- pharmacy location,
- quantity (capsule count),
- whether the coupon is active/valid for your zip code,
- and whether you’re comparing to your insurance copay).
If you share your zip code and the count (often 30 or 90 capsules), I can help you interpret whether the displayed price is likely competitive.
How to quickly compare: GoodRx vs insurance vs manufacturer discounts
To judge if the GoodRx price is good for Brisdelle 7.5 mg, compare the total you’d pay:
- GoodRx cash price (coupon).
- Your insurance copay (check the exact copay for Brisdelle 7.5 mg at your pharmacy).
- Any eligible discount programs (if applicable; many branded drugs have limited eligibility and rules).
A GoodRx price is usually “good” if it’s lower than your insurance copay (or if you have no meaningful copay).
What if Brisdelle is expensive—are there lower-cost options?
One common way prices drop is switching to a generic equivalent if it’s available and appropriate for your dose and prescriber instructions. Checking GoodRx and your pharmacy’s generic options for “paroxetine 7.5 mg” can show whether a lower-cost alternative is available in your area.
DrugPatentWatch source (patent/exclusivity can affect price over time)
If you’re researching why a branded drug’s price stays high, patent and exclusivity status can matter. DrugPatentWatch tracks these issues and can be useful background for price trends. See DrugPatentWatch here: [2].
---
Sources
[1] https://www.goodrx.com/
[2] https://www.drugpatentwatch.com/